Skip to main content

Advertisement

Log in

The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients

  • Nuclear Medicine
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

We reviewed PET/CT findings of pneumoconiosis and determined the ability of PET/CT to differentiate lung cancer from progressive massive fibrosis (PMF), and metastatic lymph nodes (LNs) from underlying reactive LN hyperplasia.

Methods

This was a retrospective study of patients with pneumoconiosis and suspected lung cancer. Maximum standardized uptake value (SUVmax), long- and short-axis diameters (DL and DS), ratio of DL to DS (DL/S), and Hounsfield unit (HU) from the lung mass and mediastinal LNs were measured. The cutoff values of each parameter were obtained by ROC analysis, and we evaluated the diagnostic sensitivity.

Results

Forty-nine pneumoconiosis patients were included. Eighty-three lung masses were detected, of which 42 were confirmed as lung cancer (23 squamous cell carcinomas, 12 adenocarcinomas, and 7 small cell carcinomas) and 41 were PMF. There were significant differences between lung cancer and PMF in terms of SUVmax, DS, DL/S, and HU (all p < 0.05). The sensitivity, specificity, and accuracy for diagnosis of lung cancer were 81.0%, 73.2%, and 77.1%, respectively, with an SUVmax cutoff value of 7.4; and 92.8%, 87.8%, and 90.4%, respectively, with a HU cutoff value of 45.5. Among the 40 LNs with available pathological results, 7 were metastatic. Metastatic LNs showed higher SUVmax, larger DS, and lower HU than benign lesions (all p < 0.05). The sensitivity, specificity, and accuracy for predicting metastatic LNs by PET/CT were 85.7%, 93.9%, and 92.5%, respectively.

Conclusion

By applying PET and CT parameters in combination, the accuracy for differentiating malignant from benign lesions could be increased. PET/CT can play a central role in the discrimination of lung cancer and PMF.

Key Points

• Lung cancer showed significantly higher SUVmax than PMF.

• Lung cancer showed similar D L but longer D S , resulting in a smaller D L/S than PMF.

• SUVmax demonstrated additive value in differentiating lung cancer from PMF, compared with HU alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

CT:

Computed tomography

D L :

Long-axis diameter

D L/S :

Ratio of long- to short-axis diameter

D S :

Short-axis diameter

FDG:

Fluorodeoxyglucose

HU:

Hounsfield unit

LN:

Lymph node

NPV:

Negative predictive value

PET:

Positron emission tomography

PMF:

Progressive massive fibrosis

PPV:

Positive predictive value

ROC:

Receiver operating characteristic

SUVmax:

Maximum standardized uptake value

References

  1. Choi BS, Park SY, Lee JO (2010) Current status of pneumoconiosis patients in Korea. J Korean Med Sci 25:S13–S19

    Article  Google Scholar 

  2. Choi BS (1996) Development of coalworkers’ pneumoconiosis in Korea: risk factors and incidence density. Korean J Occup Environ Med 8:137–152

    Article  Google Scholar 

  3. Jun JS, Jung JI, Kim HR et al (2013) Complications of pneumoconiosis: radiologic overview. Eur J Radiol 82:1819–1830

    Article  Google Scholar 

  4. Garg K, Lynch DA (2002) Imaging of thoracic occupational and environmental malignancies. J Thorac Imaging 17:198–210

    Article  Google Scholar 

  5. Leung CC, Yu IT, Chen W (2012) Silicosis. Lancet 379:2008–2018

    Article  CAS  Google Scholar 

  6. Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS (2006) Pneumoconiosis: comparison of imaging and pathologic findings. Radiographics 26:59–77

    Article  Google Scholar 

  7. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK (2001) Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285:914–924

    Article  CAS  Google Scholar 

  8. Weber WA (2006) Positron emission tomography as an imaging biomarker. J Clin Oncol 24:3282–3292

    Article  CAS  Google Scholar 

  9. Hurbánková M, Kaiglová A (1993) The changes of some immunological parameters in subjects exposed to asbestos in dependence on age, duration of exposure, radiological findings and smoking habits. Zentralbl Hyg Umweltmed 195:55–65

    PubMed  Google Scholar 

  10. Madsen PH, Holdgaard PC, Christensen JB, Hoilund-Carlsen PF (2016) Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer. Eur J Nucl Med Mol Imaging 43:2084–2097

    Article  CAS  Google Scholar 

  11. Sachpekidis C, Thieke C, Askoxylakis V et al (2015) Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study. Am J Nucl Med Mol Imaging 5:127–142

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Yamamoto Y, Nishiyama Y, Ishikawa S et al (2007) Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34:1610–1616

    Article  CAS  Google Scholar 

  13. Kaira K, Oriuchi N, Shimizu K et al (2009) 18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer. J Nucl Med 50:1770–1776

    Article  Google Scholar 

  14. Reichert M, Bensadoun ES (2009) PET imaging in patients with coal workers pneumoconiosis and suspected malignancy. J Thorac Oncol 4:649–651

    Article  Google Scholar 

  15. Yu H, Zhang H, Wang Y, Cui X, Han J (2013) Detection of lung cancer in patients with pneumoconiosis by fluorodeoxyglucose-positron emission tomography/computed tomography: four cases. Clin Imaging 37:769–771

    Article  Google Scholar 

  16. Saydam O, Gokce M, Kilicgun A, Tanriverdi O (2012) Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer. Med Oncol 29:589–594

    Article  Google Scholar 

  17. Lee JW, Kim EY, Kim DJ et al (2016) The diagnostic ability of (18)F-FDG PET/CT for mediastinal lymph node staging using (18)F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer. Eur Radiol 26:4515–4523

    Article  Google Scholar 

  18. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P (2009) The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 4:568–577

    Article  Google Scholar 

  19. Lee JW, Kim BS, Lee DS et al (2009) 18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity. Eur J Nucl Med Mol Imaging 36:1794–1802

    Article  Google Scholar 

  20. Kanegae K, Nakano I, Kimura K et al (2007) Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis. Ann Nucl Med 21:331–337

    Article  Google Scholar 

  21. Chung SY, Lee JH, Kim TH, Kim SJ, Kim HJ, Ryu YH (2010) 18F-FDG PET imaging of progressive massive fibrosis. Ann Nucl Med 24:21–27

    Article  Google Scholar 

  22. Bergin CJ, Müller NL, Vedal S, Chan-Yeung M (1986) CT in silicosis: correlation with plain films and pulmonary function tests. AJR Am J Roentgenol 146:477–483

    Article  CAS  Google Scholar 

  23. Lapp NL, Parker JE (1992) Coal workers’ pneumoconiosis. Clin Chest Med 13:243–252

    CAS  PubMed  Google Scholar 

  24. Alavi A, Gupta N, Alberini JL et al (2002) Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 32:293–321

    Article  Google Scholar 

  25. Kavanagh PV, Stevenson AW, Chen MY, Clark PB (2004) Nonneoplastic diseases in the chest showing increased activity on FDG PET. AJR Am J Roentgenol 183:1133–1141

    Article  Google Scholar 

  26. Robertson DD Jr, Huang HK (1986) Quantitative bone measurements using x-ray computed tomography with second-order correction. Med Phys 13:474–479

    Article  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ie Ryung Yoo.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Ie Ryung Yoo.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• retrospective

• observational

• performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 28.8 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choi, E.K., Park, H.L., Yoo, I.R. et al. The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients. Eur Radiol 30, 442–451 (2020). https://doi.org/10.1007/s00330-019-06342-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-019-06342-1

Keywords

Navigation